Skip to main content
Devonian Health Group Inc logo

Devonian Health Group Inc — Investor Relations & Filings

Ticker · GSD ISIN · CA2518341078 TSXV Manufacturing
Open in API
Filings indexed 598 across all filing types
Latest filing 2023-02-22 AGM Information
Country CA Canada
Listing TSXV GSD

About Devonian Health Group Inc

https://groupedevonian.com/

Devonian Health Group Inc. is a clinical-stage botanical pharmaceutical company specializing in the development of novel prescription therapeutic solutions for unmet medical needs. The core business involves late-stage prescription botanical drugs targeting fibroinflammatory autoimmune diseases, with a focus on gastrointestinal, dermatological, and hepatologic conditions. The company utilizes a broad-based technology platform, originating from over 20 years of research, to develop therapies that target multiple cellular pathways and regulate genes linked to these diseases. Its pipeline includes the lead product candidate, Thykamine, currently in Phase 3 clinical trials. Devonian also develops high-value dermatological products alongside its core drug development activities.

Recent filings

Filing Released Lang Actions
News release - French.pdf
AGM Information Classification · 95% confidence The document is an announcement regarding the upcoming Annual General Meeting (AGM) of Groupe Santé Devonian Inc., specifying the date, time, and format (hybrid) of the meeting. It provides logistical details for shareholders to attend either in person or virtually. There is no financial data, management discussion, or detailed report content included. The document is essentially a notice about the AGM event rather than the AGM materials or minutes themselves. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or announcements related to the AGM event.
2023-02-22 English
News release - English.pdf
AGM Information Classification · 95% confidence The document is an announcement about the upcoming Hybrid Shareholders’ Annual General and Special Meeting (AGM) of Devonian Health Group Inc., specifying the date, time, location, and access details for shareholders. It does not contain the actual AGM materials, presentations, or minutes but rather informs shareholders about the meeting logistics. The document length is 4463 characters, which is relatively short and consistent with an announcement rather than a full report. There is no financial data, voting results, or detailed meeting content included. Therefore, this document fits the category of AGM Information (AGM-R), as it is related to the Annual General Meeting but is not the full report or materials shared during the meeting itself. Confidence is high due to clear meeting announcement content and absence of other report types.
2023-02-22 English
Management information circular - English.pdf
Regulatory Filings
2023-02-15 English
Report of exempt distribution excluding schedule 1 of Form 5 (amended).pdf
Regulatory Filings
2023-02-14 English
News release - French.pdf
Regulatory Filings
2023-01-26 English
NI 44-101 Notice of intent to qualify – French.pdf
Management Reports Classification · 100% confidence The document is titled as "FORM 51-102F1 MANAGEMENT'S DISCUSSION AND ANALYSIS ("MD&A") For the Period Ended November 30, 2022". It contains detailed management discussion and analysis of financial results, business operations, investments, exploration assets, liquidity, and capital resources for a specific interim period ending November 30, 2022. The document includes substantive financial data and analysis, not just an announcement or certification. The presence of forward-looking statements, detailed financial figures, and operational commentary aligns with the characteristics of a Management Reports (MD&A) filing. Therefore, the document is best classified as a Management Reports (MDA) filing.
2023-01-12 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.